Logo
DCA

Smith & Nephew plc

eurostoxx600
SN.LHealthcareMedical Devices
£1,108.50
+1.56%
Last Price
£1,108.50
2026-06-03
24h Change
+1.56%
17.00 GBp
Volume
6.3K
Shares Traded
Data Reliability
High
9723 points (38 years)

Price History

Start a simulation with this asset

SN.L

Global parameters

Available data from 7/1/1988 to 6/3/2026

Fundamental Analysis

New
CAGR (5y)
5.73%
Revenue Growth
Net Margin
10.14%
Profitability
ROE
11.82%
Return on Equity
Debt / EBITDA
2.17
Solvency
PEG Ratio
1.19
Valuation vs Growth
Rev. Growth (TTM)
7.40%
Current Trend
Technical focus
SN.L
30d volatility
25.81%
Distance to MA50
-5.28%
Distance to MA200
-12.62%
Distance to ATH
-44.30%
Momentum 3M
-15.58%
Risk score
N/A

Volatility moderate. Momentum neutral.

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Invest in this asset
Buy on Saxo Bank
🏦Regulated Broker
🌍Global Markets Access
📈Pro Tools

Ad link. Capital at risk.

Technical Analysis & Risk

Key Metrics

CAGR5.00%
Volatility25.81%
Max Drawdown-29.32%

Momentum : SN.L

Indicateur synthétique
PEURNEUTREAVIDITÉ
45
Neutral

Risk Analysis

VaR (95%)-2.28%
DCA Health
95/100

Recent History (60 days)

DateCloseVolume
2026-06-03£1,108.506,317
2026-06-02£1,091.501,782,129
2026-06-01£1,095.000
2026-05-29£1,111.004,507,231
2026-05-28£0.004,075,486
2026-05-27£1,126.501,925,415
2026-05-26£1,133.501,712,785
2026-05-22£1,138.002,952,138
2026-05-21£1,142.500
2026-05-20£1,145.003,014,416
2026-05-19£1,157.002,584,857
2026-05-18£1,122.00551
2026-05-15£1,112.002,165,122
2026-05-14£1,104.004,380,955
2026-05-13£1,102.502,385,422
2026-05-12£1,103.006,758,286
2026-05-11£1,073.502,505,185
2026-05-08£1,093.002,316,223
2026-05-07£1,114.002,928,242
2026-05-06£1,117.505,696,463
2026-05-05£1,159.003,265,388
2026-05-01£1,147.001,316,259
2026-04-30£1,137.007,577,730
2026-04-29£1,132.501,814,681
2026-04-28£1,157.501,540,747
2026-04-27£1,182.003,052,283
2026-04-24£1,158.002,709,243
2026-04-23£1,184.502,592,677
2026-04-22£1,214.502,351,011
2026-04-21£1,221.001,283,466
2026-04-20£1,262.503,154,258
2026-04-17£1,268.002,203,810
2026-04-16£1,252.001,059,655
2026-04-15£1,262.503,051,532
2026-04-14£1,263.002,302,571
2026-04-13£1,242.001,833,030
2026-04-10£1,246.502,179,366
2026-04-09£1,227.502,690,866
2026-04-08£1,226.503,883,492
2026-04-07£1,193.008,700,253
2026-04-02£1,207.504,905,965
2026-04-01£1,199.501,573,710
2026-03-31£1,185.001,706,437
2026-03-30£1,200.501,572,991
2026-03-27£1,193.002,133,753
2026-03-26£1,195.501,633,310
2026-03-25£1,209.501,128,628
2026-03-24£1,205.005,705,998
2026-03-23£1,187.506,420,770
2026-03-20£1,200.505,897,866
2026-03-19£1,205.502,037,386
2026-03-18£1,251.501,790,990
2026-03-17£1,251.501,564,472
2026-03-16£1,241.50900,807
2026-03-13£1,248.001,741,482
2026-03-12£1,240.503,115,096
2026-03-11£1,243.502,712,852
2026-03-10£1,232.002,853,767
2026-03-09£1,252.002,288,713
2026-03-06£1,284.502,230,477

Recent Dividends

DateAmount
2026-03-26+£18.07
2025-10-02+£11.26
2025-03-27+£17.48
2024-10-03+£11.10
2024-03-28+£18.49
2023-10-05+£11.89
2023-03-30+£18.38
2022-09-29+£12.91
2022-03-31+£18.40
2021-09-30+£10.50
2021-04-01+£16.62
2020-10-01+£11.07
2020-04-02+£18.66
2019-10-03+£11.50
2019-04-04+£16.99
2018-10-04+£10.67
2018-04-05+£16.24
2017-10-05+£9.34
2017-03-30+£14.42
2016-10-06+£10.08

Related Assets